Cargando…
Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations
Supplemental Digital Content is Available in the Text.
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
JAIDS Journal of Acquired Immune Deficiency Syndromes
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830961/ https://www.ncbi.nlm.nih.gov/pubmed/31425317 http://dx.doi.org/10.1097/QAI.0000000000002153 |
| _version_ | 1783465867079581696 |
|---|---|
| author | Wong, Alexander Goldstein, Deborah Mallolas, Josep DeJesus, Edwin Johnson, Margaret Molina, Jean-Michel Pozniak, Anton Rodgers, Anthony Teal, Valerie Hepler, Deborah Kumar, Sushma Sklar, Peter Hanna, George J. Hwang, Carey Badshah, Cyrus Teppler, Hedy |
| author_facet | Wong, Alexander Goldstein, Deborah Mallolas, Josep DeJesus, Edwin Johnson, Margaret Molina, Jean-Michel Pozniak, Anton Rodgers, Anthony Teal, Valerie Hepler, Deborah Kumar, Sushma Sklar, Peter Hanna, George J. Hwang, Carey Badshah, Cyrus Teppler, Hedy |
| author_sort | Wong, Alexander |
| collection | PubMed |
| description | Supplemental Digital Content is Available in the Text. |
| format | Online Article Text |
| id | pubmed-6830961 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | JAIDS Journal of Acquired Immune Deficiency Syndromes |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68309612019-11-26 Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations Wong, Alexander Goldstein, Deborah Mallolas, Josep DeJesus, Edwin Johnson, Margaret Molina, Jean-Michel Pozniak, Anton Rodgers, Anthony Teal, Valerie Hepler, Deborah Kumar, Sushma Sklar, Peter Hanna, George J. Hwang, Carey Badshah, Cyrus Teppler, Hedy J Acquir Immune Defic Syndr Letters to the Editor Supplemental Digital Content is Available in the Text. JAIDS Journal of Acquired Immune Deficiency Syndromes 2019-12-01 2019-08-16 /pmc/articles/PMC6830961/ /pubmed/31425317 http://dx.doi.org/10.1097/QAI.0000000000002153 Text en Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | Letters to the Editor Wong, Alexander Goldstein, Deborah Mallolas, Josep DeJesus, Edwin Johnson, Margaret Molina, Jean-Michel Pozniak, Anton Rodgers, Anthony Teal, Valerie Hepler, Deborah Kumar, Sushma Sklar, Peter Hanna, George J. Hwang, Carey Badshah, Cyrus Teppler, Hedy Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations |
| title | Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations |
| title_full | Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations |
| title_fullStr | Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations |
| title_full_unstemmed | Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations |
| title_short | Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations |
| title_sort | efficacy and safety of doravirine/lamivudine/tenofovir disoproxil fumarate (dor/3tc/tdf) in treatment-naive adults with hiv-1 and transmitted nonnucleoside reverse transcriptase inhibitor resistance mutations |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830961/ https://www.ncbi.nlm.nih.gov/pubmed/31425317 http://dx.doi.org/10.1097/QAI.0000000000002153 |
| work_keys_str_mv | AT wongalexander efficacyandsafetyofdoravirinelamivudinetenofovirdisoproxilfumaratedor3tctdfintreatmentnaiveadultswithhiv1andtransmittednonnucleosidereversetranscriptaseinhibitorresistancemutations AT goldsteindeborah efficacyandsafetyofdoravirinelamivudinetenofovirdisoproxilfumaratedor3tctdfintreatmentnaiveadultswithhiv1andtransmittednonnucleosidereversetranscriptaseinhibitorresistancemutations AT mallolasjosep efficacyandsafetyofdoravirinelamivudinetenofovirdisoproxilfumaratedor3tctdfintreatmentnaiveadultswithhiv1andtransmittednonnucleosidereversetranscriptaseinhibitorresistancemutations AT dejesusedwin efficacyandsafetyofdoravirinelamivudinetenofovirdisoproxilfumaratedor3tctdfintreatmentnaiveadultswithhiv1andtransmittednonnucleosidereversetranscriptaseinhibitorresistancemutations AT johnsonmargaret efficacyandsafetyofdoravirinelamivudinetenofovirdisoproxilfumaratedor3tctdfintreatmentnaiveadultswithhiv1andtransmittednonnucleosidereversetranscriptaseinhibitorresistancemutations AT molinajeanmichel efficacyandsafetyofdoravirinelamivudinetenofovirdisoproxilfumaratedor3tctdfintreatmentnaiveadultswithhiv1andtransmittednonnucleosidereversetranscriptaseinhibitorresistancemutations AT pozniakanton efficacyandsafetyofdoravirinelamivudinetenofovirdisoproxilfumaratedor3tctdfintreatmentnaiveadultswithhiv1andtransmittednonnucleosidereversetranscriptaseinhibitorresistancemutations AT rodgersanthony efficacyandsafetyofdoravirinelamivudinetenofovirdisoproxilfumaratedor3tctdfintreatmentnaiveadultswithhiv1andtransmittednonnucleosidereversetranscriptaseinhibitorresistancemutations AT tealvalerie efficacyandsafetyofdoravirinelamivudinetenofovirdisoproxilfumaratedor3tctdfintreatmentnaiveadultswithhiv1andtransmittednonnucleosidereversetranscriptaseinhibitorresistancemutations AT heplerdeborah efficacyandsafetyofdoravirinelamivudinetenofovirdisoproxilfumaratedor3tctdfintreatmentnaiveadultswithhiv1andtransmittednonnucleosidereversetranscriptaseinhibitorresistancemutations AT kumarsushma efficacyandsafetyofdoravirinelamivudinetenofovirdisoproxilfumaratedor3tctdfintreatmentnaiveadultswithhiv1andtransmittednonnucleosidereversetranscriptaseinhibitorresistancemutations AT sklarpeter efficacyandsafetyofdoravirinelamivudinetenofovirdisoproxilfumaratedor3tctdfintreatmentnaiveadultswithhiv1andtransmittednonnucleosidereversetranscriptaseinhibitorresistancemutations AT hannageorgej efficacyandsafetyofdoravirinelamivudinetenofovirdisoproxilfumaratedor3tctdfintreatmentnaiveadultswithhiv1andtransmittednonnucleosidereversetranscriptaseinhibitorresistancemutations AT hwangcarey efficacyandsafetyofdoravirinelamivudinetenofovirdisoproxilfumaratedor3tctdfintreatmentnaiveadultswithhiv1andtransmittednonnucleosidereversetranscriptaseinhibitorresistancemutations AT badshahcyrus efficacyandsafetyofdoravirinelamivudinetenofovirdisoproxilfumaratedor3tctdfintreatmentnaiveadultswithhiv1andtransmittednonnucleosidereversetranscriptaseinhibitorresistancemutations AT tepplerhedy efficacyandsafetyofdoravirinelamivudinetenofovirdisoproxilfumaratedor3tctdfintreatmentnaiveadultswithhiv1andtransmittednonnucleosidereversetranscriptaseinhibitorresistancemutations |